Other tumor markers demonstrated lesser sensitivity: CEA (48.2%) > CYFRA 21-1 (44%) > CA-125 (22%) > CA 15-3 (19%) > SCC (18.4%) > CA 19-9 (10%) > NSE (9%). The gene discussed is ENO2; the disease is neoplasm.